Study of BAY43-9006 in Patients With Unresectable and/or Metastatic Renal Cell Cancer

Clinical trial NCT00073307 · COMPLETED

Trial details

NCT number: NCT00073307
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Carcinoma, Renal Cell

Start date: 2003-11-01
Primary completion: 2006-09-01
Enrollment: 903

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.